NIH Genetic and Rare Diseases Information Center (GARD)orphan drugsOrphanetrare diseasesThis column profiles three important online resources for rare disorder information. The National Organization for Rare Disorders (NORD) Rare Disease Database set the standard for thorough, detailed monographs on rare ...
On the fifth annual Rare Disease Day, the National Eye Institute (NEI), a part of the National Institutes of Health, joins patients and organizations around the world to raise awareness of rare diseases, celebrate advances in treatment, and pledge continued support of rare disease ...
Characteristics of walkable built environments and BMI z-scores in children: evidence from a large electronic health record database. Environ Health Perspect. 2014;122:1359–65. Article PubMed PubMed Central Google Scholar Bancroft C, Joshi S, Rundle A, Hutson M, Chong C, Weiss CC, et al...
In 2007, the US National Institutes of Health (NIH) introduced the Genome-Wide Association Studies (GWAS) Policy and the database of Genotypes and Phenotypes (dbGaP) to facilitate 'controlled' access to GWAS data based on participants' informed consent. dbGaP has provided 2,221 investigators acce...
The proposed policy would require that all NIH-funded clinical trials be registered in ClinicalTrials.gov and that summary results be posted to the database in a timely matter. Both documents are open for a 90-day public comment period, and comments will be taken into consideration before ...
NIH Genetic and Rare Diseases Information Center (GARD)orphan drugsOrphanetrare diseasesThis column profiles three important online resources for rare disorder information. The National Organization for Rare Disorders (NORD) Rare Disease Database set the standard for thorough, detailed monographs on ra...
To our knowledge, this description of a longitudinal study in PWS represents the largest and most comprehensive cohort useful for investigators in planning comparable studies in other rare disorders. Ongoing studies utilizing this database should have a direct impact on care and services, diagnosis, ...
National Institutes of Health (NIH) to develop drugs for rare diseases. The new NIH project attempts to organize its own pipeline of facilities and cooperating academic researchers to carry preclinical and clinical testing. According to Stephen Groft, director of the NIH Office of Rare Diseases ...
To our knowledge, this description of a longitudinal study in PWS represents the largest and most comprehensive cohort useful for investigators in planning comparable studies in other rare disorders. Ongoing studies utilizing this database should have a direct impact on care and services, diagnosis, ...
NIH Partners with Vtesse Inc. to Treat Rare DiseaseGulin, Alissa